Novartis AG
(NYSE : NVS)

( )
NVS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.07%134.840.7%$958.74m
BMYBristol-Myers Squibb Co.
-1.62%57.641.4%$819.40m
MRKMerck & Co., Inc.
-0.88%84.150.7%$764.95m
PFEPfizer Inc.
-0.22%37.200.9%$741.07m
ABBVAbbVie, Inc.
0.06%88.682.3%$691.63m
LLYEli Lilly & Co.
0.76%114.051.1%$411.52m
NVSNovartis AG
0.34%90.350.2%$154.11m
AZNAstraZeneca Plc
1.01%47.921.2%$152.46m
RETAReata Pharmaceuticals, Inc.
4.79%208.443.7%$144.22m
GSKGlaxoSmithKline Plc
0.57%44.340.2%$126.72m
NVONovo Nordisk A/S
-0.38%57.060.1%$82.13m
KRTXKaruna Therapeutics, Inc.
442.99%96.000.0%$74.98m
SNYSanofi
1.30%46.710.2%$66.68m
RARXRa Pharmaceuticals, Inc.
-0.09%46.710.8%$36.71m
CNSTConstellation Pharmaceuticals, Inc.
1.77%39.160.0%$32.97m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.